Skip to main content
Caplight Logo









StratifAI GmbH

StratifAI GmbH

Private
BerlinHealthcare & Life Scienceshttps://www.stratifai.com/

Last Round

Early Funding

Sep 30, 2025

Est. Valuation

$55M

Total Funding Raised

$16.35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

StratifAI GmbH is a precision oncology company that develops multimodal AI models to improve cancer diagnosis and treatment through its proprietary biomarker discovery platform, Polaris™.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportmedical AIbiomarker discoveryAI diagnosticsmedical data validationhealthcare analyticshealth techprecision medicinediagnostic softwaremultimodal AIclinical workflowclinical researchmedtechSaaSdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StratifAI GmbH Comparables

Compare StratifAI GmbH with similar companies based on industry and business-model similarity.

StratifAI GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Imagene AI
82%
Aignostics
79%
BioAI Health
77%

StratifAI GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 30, 2025
Pre SeedSep 2, 2024

Key People

Founding team and executive leadership

Firas Khader

CTO & Co-founder

Founding Team

Omar El Nahhas

CEO & Co-founder

Founding Team

StratifAI GmbH Investors

Notable investors and investment history

StratifAI GmbH investors
InvestorRounds
Neulogy VenturesPre Seed
Arve CapitalPre Seed, Early Funding
AlvenEarly Funding
Heliad AGEarly Funding
Picus CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 56% MoM.

  • Jan 5, 2026

    Monthly visitors increased 82% MoM.

StratifAI GmbH Filings

Explore SEC and related filing metadata, where available.

StratifAI GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about StratifAI GmbH's valuation, stock price, and market status.

Is StratifAI GmbH a public or private company?

StratifAI GmbH is a private company.

What is the current stock price of StratifAI GmbH?

StratifAI GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is StratifAI GmbH worth (valuation)?

Valuation information for StratifAI GmbH is not publicly available.

Can I buy StratifAI GmbH stock?

StratifAI GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was StratifAI GmbH's last funding round?

StratifAI GmbH's most recent funding round was VC Round on September 30, 2025.

Who are the main investors in StratifAI GmbH?

Key investors in StratifAI GmbH include Neulogy Ventures, Alven, Picus Capital.

Will StratifAI GmbH IPO soon?

No public IPO plans have been announced for StratifAI GmbH.

How can I track StratifAI GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StratifAI GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range13
Year Founded2023
Last FundingSep 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?